Background
- Design of various clinpharm / phase 2a studies and preparation of protocol synopsis
- Non-compartmental and compartmental analysis of PK data, preparation of PK reports
- Preparation of clinical pharmacology sections of regulatory submissions
- Assistance in communications with the regulatory agencies
PK/PD Analysis
- Non-compartmental analysis of preclinical and clinical PK data
- Population PK/PD modeling and simulation
- Preparation of study reports
Business Development
- Representing candidate drugs to potential partners
- General guidance in promoting candidate drugs for co-development with larger pharmaceutical companies
|